366 related articles for article (PubMed ID: 10712632)
1. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors.
Valverde O; Ledent C; Beslot F; Parmentier M; Roques BP
Eur J Neurosci; 2000 Feb; 12(2):533-9. PubMed ID: 10712632
[TBL] [Abstract][Full Text] [Related]
2. Effects of morphine-3-glucuronide on the antinociceptive activity of peptide and nonpeptide opioid receptor agonists in mice.
Bian JT; Bhargava HN
Peptides; 1996; 17(8):1415-9. PubMed ID: 8971939
[TBL] [Abstract][Full Text] [Related]
3. Interactions of cocaine with morphine, U-50,488H and [D-Pen2, D-Pen5]enkaphalin.
Bhargava HN; Cao YJ
Peptides; 1998; 19(3):563-8. PubMed ID: 9533646
[TBL] [Abstract][Full Text] [Related]
4. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
5. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
Bhargava HN; Cao YJ; Zhao GM
Brain Res; 1997 Mar; 752(1-2):234-8. PubMed ID: 9106462
[TBL] [Abstract][Full Text] [Related]
6. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
7. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
[TBL] [Abstract][Full Text] [Related]
8. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
Lohmann AB; Welch SP
Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
[TBL] [Abstract][Full Text] [Related]
9. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
[TBL] [Abstract][Full Text] [Related]
10. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice.
Doğrul A; Yeşilyurt Ö; Işmer A; Güzeldemir EM
Pain; 2001 Jul; 93(1):61-68. PubMed ID: 11406339
[TBL] [Abstract][Full Text] [Related]
11. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation by muscimol and baclofen on antinociception induced by morphine, beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Kim YH; Choi YS; Yoo JS; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):614-9. PubMed ID: 9053732
[TBL] [Abstract][Full Text] [Related]
13. Effect of 7-nitroindazole on tolerance to morphine, U-50,488H and [D-Pen2, D-Pen5] enkephalin in mice.
Bhargava HN; Cao YJ; Zhao GM
Peptides; 1997; 18(6):797-800. PubMed ID: 9285927
[TBL] [Abstract][Full Text] [Related]
14. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
15. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
16. Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
Cao YJ; Bhargava HN
Brain Res; 1997 Mar; 752(1-2):250-4. PubMed ID: 9106464
[TBL] [Abstract][Full Text] [Related]
17. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
18. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
20. The effect of intrathecal mu, delta, kappa, and alpha-2 agonists on thermal hyperalgesia induced by mild burn on hind paw in rats.
Kim HJ; Seol TK; Lee HJ; Yaksh TL; Jun JH
J Anesth; 2011 Dec; 25(6):884-91. PubMed ID: 21983967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
